MedPath

Influenza, pneumococcus, and herpes zoster vaccination among patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and inflammatory bowel disease, and the effect of reminders on vaccination rates in Australian general practice

Not Applicable
Active, not recruiting
Conditions
Influenza
Pneumococcus
Herpes Zoster
Rheumatoid arthritis
Inflammatory bowel disease
Psoriatic arthritis
Ankylosing spondylitis
Crohn's Disease
Public Health - Health promotion/education
Inflammatory and Immune System - Rheumatoid arthritis
Registration Number
ACTRN12619001221145
Lead Sponsor
The University of Adelaide
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
All
Target Recruitment
1903
Inclusion Criteria

All patients with immune-mediated inflammatory diseases (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or inflammatory bowel disease) from Australian general practices using the DCP software that agreed to be part of this study. All GPs and registered nurses from participant practices will be invited to a training session about appropriate vaccinations for patients with immune-mediated inflammatory diseases.

Exclusion Criteria

Patients who have already received the immunisations of interest, patients with contraindication to the relevant vaccine. All GPs and registered nurses who do not accept to participate in the educational activities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in influenza immunisation status according to electronic medical records[18 months from the beginning of the study];Change in pneumococcus immunisation according to electronic medical records[18 months from the beginning of the study];Change in herpes zoster immunisation status according to electronic medical records[18 months from the beginning of the study]
Secondary Outcome Measures
NameTimeMethod
Change in GPs and registered nurses confidence in vaccination recommendations for patients with immune-mediated inflammatory conditions through educational activities, which will be evaluated through interviews and/or focus groups, using a semi-structured questionnaire designed specifically for this study.[First questionnaire/interview will happen in the beginning of the study (before the use of reminders), the second one soon after the educational activity, and the last one in the end of the study (18 months form the beginning of the study).]
© Copyright 2025. All Rights Reserved by MedPath